Biomaterial Database

B cell dysfunction in renal allograft recipients. 1987

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Department of Immunology, Medical School, Warsaw, Poland.

UI	MeSH Term	Description	Entries
D008213	Lymphocyte Activation	Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.	Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011971	Receptors, Immunologic	Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.	Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D003524	Cyclosporins	A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.	Cyclosporines
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379	Azathioprine	An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)	Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D001402	B-Lymphocytes	Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.	B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D016030	Kidney Transplantation	The transference of a kidney from one human or animal to another.	Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Cyclosporine-induced renal dysfunction in human renal allograft recipients.

December 1989, Transplantation,

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Graft dysfunction and polyomavirus infection in renal allograft recipients.

May 2002, Transplantation proceedings,

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Vitamin C improves endothelial dysfunction in renal allograft recipients.

June 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients.

May 1979, Archives of surgery (Chicago, Ill. : 1960),

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Risk factors for chronic renal dysfunction in cardiac allograft recipients.

January 2000, Nephron,

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Cell-mediated lympholysis studies in renal allograft recipients.

March 1981, Transplantation,

J Juskowa, and M Wasik, and M Nowaczyk, and A Górski

Suppressor cell activity in human renal allograft recipients.

January 1981, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,